These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17521525)

  • 1. Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression.
    Gonzalez-Calero L; Martin-Lorenzo M; de la Cuesta F; Maroto AS; Baldan-Martin M; Ruiz-Hurtado G; Pulido-Olmo H; Segura J; Barderas MG; Ruilope LM; Vivanco F; Alvarez-Llamas G
    Cardiovasc Diabetol; 2016 Jan; 15():8. PubMed ID: 26772976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes.
    Molitch ME; Adler AI; Flyvbjerg A; Nelson RG; So WY; Wanner C; Kasiske BL; Wheeler DC; de Zeeuw D; Mogensen CE
    Kidney Int; 2015 Jan; 87(1):20-30. PubMed ID: 24786708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Advances in the research of diabetic nephropathy.
    Abu-Farha M; Iizuka K; Yabe D; Al-Mulla F; Abubaker J
    Front Endocrinol (Lausanne); 2022; 13():1116188. PubMed ID: 36686433
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class Analysis.
    Jiang R; Law E; Zhou Z; Yang H; Wu EQ; Seifeldin R
    Diabetes Ther; 2018 Jun; 9(3):1021-1036. PubMed ID: 29600504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system.
    Schernthaner G; Mogensen CE; Schernthaner GH
    Diab Vasc Dis Res; 2014 Sep; 11(5):306-23. PubMed ID: 25116004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease.
    Caubet C; Lacroix C; Decramer S; Drube J; Ehrich JH; Mischak H; Bascands JL; Schanstra JP
    Pediatr Nephrol; 2010 Jan; 25(1):27-35. PubMed ID: 19603189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria.
    Persson F; Rossing P; Reinhard H; Juhl T; Stehouwer CD; Schalkwijk C; Danser AH; Boomsma F; Frandsen E; Parving HH
    Diabetes Care; 2009 Oct; 32(10):1873-9. PubMed ID: 19587362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.
    Metzger J; Luppa PB; Good DM; Mischak H
    Crit Rev Clin Lab Sci; 2009; 46(3):129-52. PubMed ID: 19404829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

  • 10. Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring.
    Rossing K
    Dan Med Bull; 2007 May; 54(2):79-98. PubMed ID: 17521525
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diabetic nephropathy].
    Morcos M; Zeier M; Schwenger V
    Dtsch Med Wochenschr; 2007 May; 132(19):1039-42. PubMed ID: 17476634
    [No Abstract]   [Full Text] [Related]  

  • 12. [The kidneys and diabetes].
    Rüster C; Sämann A; Wolf G
    Dtsch Med Wochenschr; 2008 Sep; 133(37):1848-52. PubMed ID: 18770486
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prediction, screening and treatment of renal complications of diabetes].
    Marre M; Larger E
    Rev Prat; 2001 Oct; 51(16):1769-75. PubMed ID: 11795120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
    Luño J; Valderrábano F
    An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.